Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001889974 | SCV002142747 | uncertain significance | not provided | 2023-06-14 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt C3 protein function. ClinVar contains an entry for this variant (Variation ID: 1377734). This variant has not been reported in the literature in individuals affected with C3-related conditions. This variant is present in population databases (rs749836289, gnomAD 0.008%). This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 568 of the C3 protein (p.Gly568Ser). |
Fulgent Genetics, |
RCV005016722 | SCV005649895 | uncertain significance | Age related macular degeneration 9; Atypical hemolytic-uremic syndrome with C3 anomaly; Complement component 3 deficiency | 2024-05-22 | criteria provided, single submitter | clinical testing |